世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

G-CSF注射の世界市場インサイト、2029年までの予測


Global G-CSF Injection Market Insights, Forecast to 2029

世界のG-CSF注射剤市場は、2022年の100万米ドルに比べ、2023年には100万米ドルに達すると予想され、%プラスの成長が見込まれています。川下産業からの需要の増加を背景に、G-CSF注射剤産業は2029年に百万米ドルに... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2023年12月5日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

世界のG-CSF注射剤市場は、2022年の100万米ドルに比べ、2023年には100万米ドルに達すると予想され、%プラスの成長が見込まれています。川下産業からの需要の増加を背景に、G-CSF注射剤産業は2029年に百万米ドルに達すると評価されている。2023年から2029年までのCAGRは%である。

G-CSF 注射の世界的な主要メーカーには、アムジェン社、ファイザー社、サンド社（ノバルティス）、スペクトラム・ファーマシューティカルズ社、バイオコン・バイオロジクス社、コーヘルス・バイオサイエンシズ社、テバ・ファーマシューティカルズ社、サノフィ社、イーファン製薬社などがあります。アムジェン社、ファイザー社、サンド社（ノバルティス社）が上位3社であり、2022年の売上高シェアは全体の1%である。
消費地域を考慮すると、2022年のG-CSF注射剤の販売量は、北米、ヨーロッパ、アジア太平洋地域に占める割合が高い。アジア太平洋地域は、2023年から2029年までのCAGRが%であり、2029年の売上シェアは%であることから、急成長を遂げると推定される。さらに、中国はG-CSF注射剤市場全体において重要な役割を担っており、業界関係者や投資家の注目を集めると推定される。

G-CSF注射剤は長時間作用型G-CSF注射剤と短時間作用型G-CSF注射剤などに分けられる。長時間作用型G-CSF注射剤は市場の主流製品であり、2022年の世界売上シェアは%で、2029年にはその割合は%になると予想される。
G-CSF注射剤は、腫瘍性疾患、血液疾患、その他など様々な分野で広く使用されている。腫瘍性疾患は、G-CSF注射剤産業の発展を最も支えている。2022年、世界のG-CSF注射剤の売上は、腫瘍性疾患分野への売上が占め、その割合は2029年には%に達するだろう。

レポートの対象
この調査レポートは、2018年から2029年までの世界のG-CSF注射剤市場の概観を紹介し、読者が多角的に世界のG-CSF注射剤市場を包括的に理解することを目的としています。2018年から2029年までの地域別の売上高、収益、2018年から2023年までのメーカーの売上高、価格、収益、粗利益率などの項目を分析しています。さらに、2018年から2029年までの各地域における製品タイプおよび用途の売上高および収益も取り上げています。

レポートに掲載されているメーカー、タイプ、アプリケーション、地域
企業別
サンド（ノバルティス）
スペクトラム・ファーマシューティカルズ
バイオコン・バイオロジクス社
コーヘラス・バイオサイエンシズ社
テバ・ファーマシューティカル
サノフィ
イーファン製薬
CSPC
江蘇恒瑞医薬
斉魯薬業
山東克星生物製薬
タイプ別
長時間作用型G-CSF注射剤
短時間作用型G-CSF注射剤
用途別セグメント
腫瘍性疾患
血液疾患
その他
地域別セグメント
米国およびカナダ
米国
カナダ
中国
アジア（中国を除く）
日本
韓国
中国 台湾
東南アジア
インド
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
ラテンアメリカ、中東、アフリカ
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

章の概要
第1章：製品の定義、種類、用途の紹介
第2章：2018年から2029年までの地域別売上高および販売量分析
第3章：メーカーのG-CSF注射の工場分布、G-CSF注射の商業日、提供される製品タイプ、M&Aおよび拡大活動を含む、メーカーの売上高、収益および価格分析。
第4章：2018年から2029年までの世界のタイプ別製品売上高、収益、価格分析
第5章：2018年から2029年までの世界的な用途別製品売上高、収益および価格分析
第6章：米国・カナダにおける2018年から2029年までのタイプ別・用途別製品売上高、収益分析2018年から2029年までの米国＆カナダにおける各国別製品売上高、収益分析
第7章：ヨーロッパにおける2018年から2029年までの製品の販売、タイプ別および用途別収益分析。2018年から2029年までの欧州各国の製品売上高、収益分析
第8章：2018年から2029年までの中国における製品の売上高、タイプ別および用途別の収益分析。2018年から2029年までの中国の製品売上高、収益分析
第9章：2018年から2029年までのアジア（中国を除く）における製品売上高、タイプ別および用途別収益分析。2018年から2029年までのアジア（中国を除く）各国の製品売上高、収益分析
第10章：2018年から2029年までの中東、アフリカ、ラテンアメリカにおける製品の販売、タイプ別および用途別収益分析。2018年から2029年までの中東、アフリカ、ラテンアメリカの各国における製品売上高、収益分析。
第11章：メーカーの概要、企業の基本情報、主要事業、G-CSF注射の紹介などをカバーしています。2018年から2023年までの各社のG-CSF注射の売上高、収益、価格、およびグロスマージン
第12章：原材料、製造コストのような産業チェーン分析。市場チャネル、流通業者、顧客分析
第13章：市場機会と課題分析
第14章：G-CSF注射剤に関するQYResearchの結論
第15章：QYResearchが採用した方法論とデータソース


ページTOPに戻る


目次

1 Study Coverage
1.1 G-CSF Injection Product Introduction
1.2 Market by Type
1.2.1 Global G-CSF Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Long-acting G-CSF Injection
1.2.3 Short-acting G-CSF Injection
1.3 Market by Application
1.3.1 Global G-CSF Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Neoplastic Diseases
1.3.3 Blood Disorders
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global G-CSF Injection Sales Estimates and Forecasts 2018-2029
2.2 Global G-CSF Injection Revenue by Region
2.2.1 Global G-CSF Injection Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global G-CSF Injection Revenue by Region (2018-2023)
2.2.3 Global G-CSF Injection Revenue by Region (2024-2029)
2.2.4 Global G-CSF Injection Revenue Market Share by Region (2018-2029)
2.3 Global G-CSF Injection Sales Estimates and Forecasts 2018-2029
2.4 Global G-CSF Injection Sales by Region
2.4.1 Global G-CSF Injection Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global G-CSF Injection Sales by Region (2018-2023)
2.4.3 Global G-CSF Injection Sales by Region (2024-2029)
2.4.4 Global G-CSF Injection Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global G-CSF Injection Sales by Manufacturers
3.1.1 Global G-CSF Injection Sales by Manufacturers (2018-2023)
3.1.2 Global G-CSF Injection Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of G-CSF Injection in 2022
3.2 Global G-CSF Injection Revenue by Manufacturers
3.2.1 Global G-CSF Injection Revenue by Manufacturers (2018-2023)
3.2.2 Global G-CSF Injection Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by G-CSF Injection Revenue in 2022
3.3 Global Key Players of G-CSF Injection, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global G-CSF Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global G-CSF Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of G-CSF Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of G-CSF Injection, Product Offered and Application
3.8 Global Key Manufacturers of G-CSF Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global G-CSF Injection Sales by Type
4.1.1 Global G-CSF Injection Historical Sales by Type (2018-2023)
4.1.2 Global G-CSF Injection Forecasted Sales by Type (2024-2029)
4.1.3 Global G-CSF Injection Sales Market Share by Type (2018-2029)
4.2 Global G-CSF Injection Revenue by Type
4.2.1 Global G-CSF Injection Historical Revenue by Type (2018-2023)
4.2.2 Global G-CSF Injection Forecasted Revenue by Type (2024-2029)
4.2.3 Global G-CSF Injection Revenue Market Share by Type (2018-2029)
4.3 Global G-CSF Injection Price by Type
4.3.1 Global G-CSF Injection Price by Type (2018-2023)
4.3.2 Global G-CSF Injection Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global G-CSF Injection Sales by Application
5.1.1 Global G-CSF Injection Historical Sales by Application (2018-2023)
5.1.2 Global G-CSF Injection Forecasted Sales by Application (2024-2029)
5.1.3 Global G-CSF Injection Sales Market Share by Application (2018-2029)
5.2 Global G-CSF Injection Revenue by Application
5.2.1 Global G-CSF Injection Historical Revenue by Application (2018-2023)
5.2.2 Global G-CSF Injection Forecasted Revenue by Application (2024-2029)
5.2.3 Global G-CSF Injection Revenue Market Share by Application (2018-2029)
5.3 Global G-CSF Injection Price by Application
5.3.1 Global G-CSF Injection Price by Application (2018-2023)
5.3.2 Global G-CSF Injection Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada G-CSF Injection Market Size by Type
6.1.1 US & Canada G-CSF Injection Sales by Type (2018-2029)
6.1.2 US & Canada G-CSF Injection Revenue by Type (2018-2029)
6.2 US & Canada G-CSF Injection Market Size by Application
6.2.1 US & Canada G-CSF Injection Sales by Application (2018-2029)
6.2.2 US & Canada G-CSF Injection Revenue by Application (2018-2029)
6.3 US & Canada G-CSF Injection Market Size by Country
6.3.1 US & Canada G-CSF Injection Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada G-CSF Injection Sales by Country (2018-2029)
6.3.3 US & Canada G-CSF Injection Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe G-CSF Injection Market Size by Type
7.1.1 Europe G-CSF Injection Sales by Type (2018-2029)
7.1.2 Europe G-CSF Injection Revenue by Type (2018-2029)
7.2 Europe G-CSF Injection Market Size by Application
7.2.1 Europe G-CSF Injection Sales by Application (2018-2029)
7.2.2 Europe G-CSF Injection Revenue by Application (2018-2029)
7.3 Europe G-CSF Injection Market Size by Country
7.3.1 Europe G-CSF Injection Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe G-CSF Injection Sales by Country (2018-2029)
7.3.3 Europe G-CSF Injection Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China G-CSF Injection Market Size
8.1.1 China G-CSF Injection Sales (2018-2029)
8.1.2 China G-CSF Injection Revenue (2018-2029)
8.2 China G-CSF Injection Market Size by Application
8.2.1 China G-CSF Injection Sales by Application (2018-2029)
8.2.2 China G-CSF Injection Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia G-CSF Injection Market Size by Type
9.1.1 Asia G-CSF Injection Sales by Type (2018-2029)
9.1.2 Asia G-CSF Injection Revenue by Type (2018-2029)
9.2 Asia G-CSF Injection Market Size by Application
9.2.1 Asia G-CSF Injection Sales by Application (2018-2029)
9.2.2 Asia G-CSF Injection Revenue by Application (2018-2029)
9.3 Asia G-CSF Injection Sales by Region
9.3.1 Asia G-CSF Injection Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia G-CSF Injection Revenue by Region (2018-2029)
9.3.3 Asia G-CSF Injection Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America G-CSF Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America G-CSF Injection Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America G-CSF Injection Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America G-CSF Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America G-CSF Injection Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America G-CSF Injection Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America G-CSF Injection Sales by Country
10.3.1 Middle East, Africa and Latin America G-CSF Injection Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America G-CSF Injection Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America G-CSF Injection Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Information
11.1.2 Amgen Inc. Overview
11.1.3 Amgen Inc. G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Amgen Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Inc. Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Pfizer G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Information
11.3.2 Sandoz (Novartis) Overview
11.3.3 Sandoz (Novartis) G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Sandoz (Novartis) G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sandoz (Novartis) Recent Developments
11.4 Spectrum Pharmaceuticals
11.4.1 Spectrum Pharmaceuticals Company Information
11.4.2 Spectrum Pharmaceuticals Overview
11.4.3 Spectrum Pharmaceuticals G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Spectrum Pharmaceuticals G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Spectrum Pharmaceuticals Recent Developments
11.5 Biocon Biologics Inc.
11.5.1 Biocon Biologics Inc. Company Information
11.5.2 Biocon Biologics Inc. Overview
11.5.3 Biocon Biologics Inc. G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Biocon Biologics Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biocon Biologics Inc. Recent Developments
11.6 Coherus BioSciences, Inc.
11.6.1 Coherus BioSciences, Inc. Company Information
11.6.2 Coherus BioSciences, Inc. Overview
11.6.3 Coherus BioSciences, Inc. G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Coherus BioSciences, Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Coherus BioSciences, Inc. Recent Developments
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Information
11.7.2 Teva Pharmaceutical Overview
11.7.3 Teva Pharmaceutical G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Teva Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Teva Pharmaceutical Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Overview
11.8.3 Sanofi G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Sanofi G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 Yifan Pharmaceutical
11.9.1 Yifan Pharmaceutical Company Information
11.9.2 Yifan Pharmaceutical Overview
11.9.3 Yifan Pharmaceutical G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Yifan Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Yifan Pharmaceutical Recent Developments
11.10 CSPC
11.10.1 CSPC Company Information
11.10.2 CSPC Overview
11.10.3 CSPC G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 CSPC G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CSPC Recent Developments
11.11 Jiangsu Hengrui Medicine
11.11.1 Jiangsu Hengrui Medicine Company Information
11.11.2 Jiangsu Hengrui Medicine Overview
11.11.3 Jiangsu Hengrui Medicine G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Jiangsu Hengrui Medicine G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jiangsu Hengrui Medicine Recent Developments
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Company Information
11.12.2 Qilu Pharmaceutical Overview
11.12.3 Qilu Pharmaceutical G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Qilu Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Qilu Pharmaceutical Recent Developments
11.13 Shan Dong Kexing Biopharm
11.13.1 Shan Dong Kexing Biopharm Company Information
11.13.2 Shan Dong Kexing Biopharm Overview
11.13.3 Shan Dong Kexing Biopharm G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Shan Dong Kexing Biopharm G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shan Dong Kexing Biopharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 G-CSF Injection Industry Chain Analysis
12.2 G-CSF Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 G-CSF Injection Production Mode & Process
12.4 G-CSF Injection Sales and Marketing
12.4.1 G-CSF Injection Sales Channels
12.4.2 G-CSF Injection Distributors
12.5 G-CSF Injection Customers
13 Market Dynamics
13.1 G-CSF Injection Industry Trends
13.2 G-CSF Injection Market Drivers
13.3 G-CSF Injection Market Challenges
13.4 G-CSF Injection Market Restraints
14 Key Findings in The Global G-CSF Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る


　

Summary

Global G-CSF Injection market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, G-CSF Injection industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2023 to 2029.

Globally, G-CSF Injection key manufacturers include Amgen Inc., Pfizer, Sandoz (Novartis), Spectrum Pharmaceuticals, Biocon Biologics Inc., Coherus BioSciences, Inc., Teva Pharmaceutical, Sanofi and Yifan Pharmaceutical, etc. Amgen Inc., Pfizer, Sandoz (Novartis) are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of G-CSF Injection were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole G-CSF Injection market and estimated to attract more attentions from industry insiders and investors.

G-CSF Injection can be divided into Long-acting G-CSF Injection and Short-acting G-CSF Injection, etc. Long-acting G-CSF Injection is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
G-CSF Injection is widely used in various fields, such as Neoplastic Diseases, Blood Disorders and Others,, etc. Neoplastic Diseases provides greatest supports to the G-CSF Injection industry development. In 2022, global % sales of G-CSF Injection went into Neoplastic Diseases filed and the proportion will reach to % in 2029.

Report Covers:
This report presents an overview of global G-CSF Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global G-CSF Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Sandoz (Novartis)
Spectrum Pharmaceuticals
Biocon Biologics Inc.
Coherus BioSciences, Inc.
Teva Pharmaceutical
Sanofi
Yifan Pharmaceutical
CSPC
Jiangsu Hengrui Medicine
Qilu Pharmaceutical
Shan Dong Kexing Biopharm
Segment by Type
Long-acting G-CSF Injection
Short-acting G-CSF Injection
Segment by Application
Neoplastic Diseases
Blood Disorders
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Product definition, type and application introduction
Chapter 2: Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3: Manufacturers’ sales, revenue and price analysis, including manufacturers’ G-CSF Injection plant distribution, commercial date of G-CSF Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4: Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5: Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6: Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7: Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8: Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9: Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10: Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11: Manufacturers’ outline, covering company’s basic information, major business, G-CSF Injection introduction, etc. G-CSF Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12: Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13: Market opportunities and challenges analysis
Chapter 14: QYResearch’s Conclusions of G-CSF Injection
Chapter 15: Methodology and Data Sources adopted by QYResearch



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 G-CSF Injection Product Introduction
1.2 Market by Type
1.2.1 Global G-CSF Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Long-acting G-CSF Injection
1.2.3 Short-acting G-CSF Injection
1.3 Market by Application
1.3.1 Global G-CSF Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Neoplastic Diseases
1.3.3 Blood Disorders
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global G-CSF Injection Sales Estimates and Forecasts 2018-2029
2.2 Global G-CSF Injection Revenue by Region
2.2.1 Global G-CSF Injection Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global G-CSF Injection Revenue by Region (2018-2023)
2.2.3 Global G-CSF Injection Revenue by Region (2024-2029)
2.2.4 Global G-CSF Injection Revenue Market Share by Region (2018-2029)
2.3 Global G-CSF Injection Sales Estimates and Forecasts 2018-2029
2.4 Global G-CSF Injection Sales by Region
2.4.1 Global G-CSF Injection Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global G-CSF Injection Sales by Region (2018-2023)
2.4.3 Global G-CSF Injection Sales by Region (2024-2029)
2.4.4 Global G-CSF Injection Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global G-CSF Injection Sales by Manufacturers
3.1.1 Global G-CSF Injection Sales by Manufacturers (2018-2023)
3.1.2 Global G-CSF Injection Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of G-CSF Injection in 2022
3.2 Global G-CSF Injection Revenue by Manufacturers
3.2.1 Global G-CSF Injection Revenue by Manufacturers (2018-2023)
3.2.2 Global G-CSF Injection Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by G-CSF Injection Revenue in 2022
3.3 Global Key Players of G-CSF Injection, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global G-CSF Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global G-CSF Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of G-CSF Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of G-CSF Injection, Product Offered and Application
3.8 Global Key Manufacturers of G-CSF Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global G-CSF Injection Sales by Type
4.1.1 Global G-CSF Injection Historical Sales by Type (2018-2023)
4.1.2 Global G-CSF Injection Forecasted Sales by Type (2024-2029)
4.1.3 Global G-CSF Injection Sales Market Share by Type (2018-2029)
4.2 Global G-CSF Injection Revenue by Type
4.2.1 Global G-CSF Injection Historical Revenue by Type (2018-2023)
4.2.2 Global G-CSF Injection Forecasted Revenue by Type (2024-2029)
4.2.3 Global G-CSF Injection Revenue Market Share by Type (2018-2029)
4.3 Global G-CSF Injection Price by Type
4.3.1 Global G-CSF Injection Price by Type (2018-2023)
4.3.2 Global G-CSF Injection Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global G-CSF Injection Sales by Application
5.1.1 Global G-CSF Injection Historical Sales by Application (2018-2023)
5.1.2 Global G-CSF Injection Forecasted Sales by Application (2024-2029)
5.1.3 Global G-CSF Injection Sales Market Share by Application (2018-2029)
5.2 Global G-CSF Injection Revenue by Application
5.2.1 Global G-CSF Injection Historical Revenue by Application (2018-2023)
5.2.2 Global G-CSF Injection Forecasted Revenue by Application (2024-2029)
5.2.3 Global G-CSF Injection Revenue Market Share by Application (2018-2029)
5.3 Global G-CSF Injection Price by Application
5.3.1 Global G-CSF Injection Price by Application (2018-2023)
5.3.2 Global G-CSF Injection Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada G-CSF Injection Market Size by Type
6.1.1 US & Canada G-CSF Injection Sales by Type (2018-2029)
6.1.2 US & Canada G-CSF Injection Revenue by Type (2018-2029)
6.2 US & Canada G-CSF Injection Market Size by Application
6.2.1 US & Canada G-CSF Injection Sales by Application (2018-2029)
6.2.2 US & Canada G-CSF Injection Revenue by Application (2018-2029)
6.3 US & Canada G-CSF Injection Market Size by Country
6.3.1 US & Canada G-CSF Injection Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada G-CSF Injection Sales by Country (2018-2029)
6.3.3 US & Canada G-CSF Injection Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe G-CSF Injection Market Size by Type
7.1.1 Europe G-CSF Injection Sales by Type (2018-2029)
7.1.2 Europe G-CSF Injection Revenue by Type (2018-2029)
7.2 Europe G-CSF Injection Market Size by Application
7.2.1 Europe G-CSF Injection Sales by Application (2018-2029)
7.2.2 Europe G-CSF Injection Revenue by Application (2018-2029)
7.3 Europe G-CSF Injection Market Size by Country
7.3.1 Europe G-CSF Injection Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe G-CSF Injection Sales by Country (2018-2029)
7.3.3 Europe G-CSF Injection Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China G-CSF Injection Market Size
8.1.1 China G-CSF Injection Sales (2018-2029)
8.1.2 China G-CSF Injection Revenue (2018-2029)
8.2 China G-CSF Injection Market Size by Application
8.2.1 China G-CSF Injection Sales by Application (2018-2029)
8.2.2 China G-CSF Injection Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia G-CSF Injection Market Size by Type
9.1.1 Asia G-CSF Injection Sales by Type (2018-2029)
9.1.2 Asia G-CSF Injection Revenue by Type (2018-2029)
9.2 Asia G-CSF Injection Market Size by Application
9.2.1 Asia G-CSF Injection Sales by Application (2018-2029)
9.2.2 Asia G-CSF Injection Revenue by Application (2018-2029)
9.3 Asia G-CSF Injection Sales by Region
9.3.1 Asia G-CSF Injection Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia G-CSF Injection Revenue by Region (2018-2029)
9.3.3 Asia G-CSF Injection Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America G-CSF Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America G-CSF Injection Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America G-CSF Injection Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America G-CSF Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America G-CSF Injection Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America G-CSF Injection Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America G-CSF Injection Sales by Country
10.3.1 Middle East, Africa and Latin America G-CSF Injection Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America G-CSF Injection Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America G-CSF Injection Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Information
11.1.2 Amgen Inc. Overview
11.1.3 Amgen Inc. G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Amgen Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Inc. Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Pfizer G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Information
11.3.2 Sandoz (Novartis) Overview
11.3.3 Sandoz (Novartis) G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Sandoz (Novartis) G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sandoz (Novartis) Recent Developments
11.4 Spectrum Pharmaceuticals
11.4.1 Spectrum Pharmaceuticals Company Information
11.4.2 Spectrum Pharmaceuticals Overview
11.4.3 Spectrum Pharmaceuticals G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Spectrum Pharmaceuticals G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Spectrum Pharmaceuticals Recent Developments
11.5 Biocon Biologics Inc.
11.5.1 Biocon Biologics Inc. Company Information
11.5.2 Biocon Biologics Inc. Overview
11.5.3 Biocon Biologics Inc. G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Biocon Biologics Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biocon Biologics Inc. Recent Developments
11.6 Coherus BioSciences, Inc.
11.6.1 Coherus BioSciences, Inc. Company Information
11.6.2 Coherus BioSciences, Inc. Overview
11.6.3 Coherus BioSciences, Inc. G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Coherus BioSciences, Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Coherus BioSciences, Inc. Recent Developments
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Information
11.7.2 Teva Pharmaceutical Overview
11.7.3 Teva Pharmaceutical G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Teva Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Teva Pharmaceutical Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Overview
11.8.3 Sanofi G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Sanofi G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 Yifan Pharmaceutical
11.9.1 Yifan Pharmaceutical Company Information
11.9.2 Yifan Pharmaceutical Overview
11.9.3 Yifan Pharmaceutical G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Yifan Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Yifan Pharmaceutical Recent Developments
11.10 CSPC
11.10.1 CSPC Company Information
11.10.2 CSPC Overview
11.10.3 CSPC G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 CSPC G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CSPC Recent Developments
11.11 Jiangsu Hengrui Medicine
11.11.1 Jiangsu Hengrui Medicine Company Information
11.11.2 Jiangsu Hengrui Medicine Overview
11.11.3 Jiangsu Hengrui Medicine G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Jiangsu Hengrui Medicine G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jiangsu Hengrui Medicine Recent Developments
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Company Information
11.12.2 Qilu Pharmaceutical Overview
11.12.3 Qilu Pharmaceutical G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Qilu Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Qilu Pharmaceutical Recent Developments
11.13 Shan Dong Kexing Biopharm
11.13.1 Shan Dong Kexing Biopharm Company Information
11.13.2 Shan Dong Kexing Biopharm Overview
11.13.3 Shan Dong Kexing Biopharm G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Shan Dong Kexing Biopharm G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shan Dong Kexing Biopharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 G-CSF Injection Industry Chain Analysis
12.2 G-CSF Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 G-CSF Injection Production Mode & Process
12.4 G-CSF Injection Sales and Marketing
12.4.1 G-CSF Injection Sales Channels
12.4.2 G-CSF Injection Distributors
12.5 G-CSF Injection Customers
13 Market Dynamics
13.1 G-CSF Injection Industry Trends
13.2 G-CSF Injection Market Drivers
13.3 G-CSF Injection Market Challenges
13.4 G-CSF Injection Market Restraints
14 Key Findings in The Global G-CSF Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

QYResearch社の医薬・ヘルスケア分野での最新刊レポート

本レポートと同じKEY WORD（injection）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/18　10:27

154.74 円

162.88 円

199.42 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.